Photochemotherapy of psoriasis: Risk : benefit ratios
- 1 January 1981
- journal article
- editorial
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 4 (1) , 90-93
- https://doi.org/10.1016/s0190-9622(81)80293-9
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Tar, ultraviolet light, PUVA, and cancerJournal of the American Academy of Dermatology, 1980
- SKIN CARCINOMA IN PATIENTS WITH PSORIASIS TREATED WITH TOPICAL TAR AND ARTIFICIAL ULTRAVIOLET RADIATIONThe Lancet, 1980
- Risk of Cutaneous Carcinoma in Patients Treated with Oral Methoxsalen Photochemotherapy for PsoriasisNew England Journal of Medicine, 1979
- Psoralen Plus Black Light Inhibits Epidermal DNA SynthesisArchives of Dermatology, 1973
- Mutagenesis in Escherichia coli IV. Photosensitization to near ultraviolet light by 8-methoxypsoralenMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1970
- The Wave Length Effect Upon Erythemal and Carcinogenic Response in Psoralen Treated Mice11From the Department of Biochemistry, The University of Texas M.D. Anderson Hospital and Tumor Institute and the Departments of Biochemistry and Dermatology, Baylor University College of Medicine, Houston, Texas. Supported by grants from the Robert A. Welch Foundation, Humble Oil and Refining Company and the National Cancer Institute (NCI 2620), U. S. Department of Health, Education and Welfare.Journal of Investigative Dermatology, 1958
- Squamous Epithelioma possibly Induced by the Therapeutic Application of TarBritish Journal of Cancer, 1956
- EPITHELIOMA FOLLOWING THE LOCAL TREATMENT OF PRURITUS ANI WITH LIQUOR PICIS CARBONISBritish Journal of Dermatology, 1948
- OCCUPATIONAL CUTANEOUS CANCER ATTRIBUTABLE TO CERTAIN CHEMICALS IN INDUSTRYBritish Medical Bulletin, 1946